- Home
- GNFT vs RGTI Comparison
GNFT vs RGTI Comparison
Compare GNFT & RGTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNFT
- RGTI
- Stock Information
- Founded
- GNFT 1999
- RGTI 2013
- Country
- GNFT France
- RGTI United States
- Employees
- GNFT N/A
- RGTI N/A
- Industry
- GNFT Biotechnology: Biological Products (No Diagnostic Substances)
- RGTI Retail: Computer Software & Peripheral Equipment
- Sector
- GNFT Health Care
- RGTI Technology
- Exchange
- GNFT Nasdaq
- RGTI Nasdaq
- Market Cap
- GNFT 190.6M
- RGTI 285.0M
- IPO Year
- GNFT 2019
- RGTI N/A
- Fundamental
- Price
- GNFT $3.67
- RGTI $11.35
- Analyst Decision
- GNFT Strong Buy
- RGTI Strong Buy
- Analyst Count
- GNFT 1
- RGTI 5
- Target Price
- GNFT $13.00
- RGTI $4.80
- AVG Volume (30 Days)
- GNFT 8.9K
- RGTI 161.8M
- Earning Date
- GNFT 09-19-2024
- RGTI 11-12-2024
- Dividend Yield
- GNFT N/A
- RGTI N/A
- EPS Growth
- GNFT N/A
- RGTI N/A
- EPS
- GNFT 0.47
- RGTI N/A
- Revenue
- GNFT $86,225,222.00
- RGTI $11,892,000.00
- Revenue This Year
- GNFT $155.44
- RGTI N/A
- Revenue Next Year
- GNFT N/A
- RGTI $47.00
- P/E Ratio
- GNFT $7.55
- RGTI N/A
- Revenue Growth
- GNFT 175.45
- RGTI N/A
- 52 Week Low
- GNFT $3.31
- RGTI $0.66
- 52 Week High
- GNFT $6.42
- RGTI $12.75
- Technical
- Relative Strength Index (RSI)
- GNFT 30.71
- RGTI 70.86
- Support Level
- GNFT $3.63
- RGTI $6.75
- Resistance Level
- GNFT $3.93
- RGTI $12.30
- Average True Range (ATR)
- GNFT 0.13
- RGTI 2.12
- MACD
- GNFT 0.03
- RGTI 0.44
- Stochastic Oscillator
- GNFT 9.93
- RGTI 85.82
About GNFT GENFIT S.A.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.
About RGTI Rigetti Computing Inc.
Rigetti Computing Inc is engaged in the business of full-stack quantum computing. Its proprietary quantum-classical infrastructure provides ultra-low latency integration with public and private clouds for high-performance practical quantum computing. The company has developed the industry's first multi-chip quantum processor for scalable quantum computing systems. Geographically, it derives a majority of its revenue from the United States.